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Abstract
Objective: An association between maternal hypoglycemia during pregnancy with fetal growth
restriction and overall perinatal mortality has been reported. In a retrospective pilot study we
found that hypoglycemia was linked with a greater number of special care/neonatal intensive care
unit admissions and approached significance in the number of women who developed preeclampsia.
That study was limited by its retrospective design, a narrow patient population and the inability to
perform multivariate analysis because of the limitations in the data points collected. This study was
undertaken to compare the perinatal outcome in pregnancies with hyoglycemia following a glucose
challenge test (GCT) to pregnancies with a normal GCT.
Methods: Obstetric patients (not pre-gestational diabetics or gestational diabetes before 24
weeks were eligible. Women with a 1 hour glucose ≤ 88 mg/dL (4.8 m/mol) following a 50-gram
oral GCT were matched with the next patient with a 1 hour glucose of 89–139 mg/dL. Pregnancy
outcomes were evaluated.
Results: Over 22 months, 436 hypoglycemic patients and 434 normal subjects were identified.
Hypoglycemia was increased in women < 25 (p = 0.003) and with pre-existing medical conditions
(p < 0.001). Hypoglycemia was decreased if pre-pregnancy BMI ≥ 30 (p = 0.008).
Preeclampsia/eclampsia was more common in hypoglycemic women. (OR = 3.13, 95% CI 1.51 –
6.51, p = 0.002) but not other intrapartum and perinatal outcomes.
Conclusion: Hypoglycemic patients are younger, have reduced pre-pregnancy weight, lower BMIs,
and are more likely to develop preeclampsia than normoglycemic women.
Background
An association between maternal hypoglycemia during
pregnancy with fetal growth restriction and overall perina-
tal mortality was reported in 1979 [1]. Since that time
other investigators have used a variety of screening meth-
ods including both oral and intravenous glucose loading
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to identify hypoglycemia in pregnancy and relate this
finding to pregnancy outcomes [2-9]. One of the most
recent studies used the 100-gram oral glucose tolerance
test and found a significantly lower incidence of both ges-
tational diabetes and neonatal birth weights [10]. The best
test to categorize pregnancies with hypoglycemia is uncer-
tain, but the most widely available and frequently used
test in most pregnancies would be the most effective
screening test if correlated with pregnancy outcomes.
Previously, we undertook a retrospective pilot study to
evaluate hypoglycemia following a 1 hour 50 g glucose
challenge test (GCT) to determine if any association could
be identified between hypoglycemia and an adverse preg-
nancy outcome [11]. That investigation found that
hypoglycemia was linked with a greater number of special
care/neonatal intensive care unit admissions and
approached significance in the number of women who
developed preeclampsia. The study was limited by its ret-
rospective design, a narrow patient population and the
inability to perform multivariate analysis because of the
limitations in the data points collected.
The purpose of this prospective study was to compare the
perinatal outcomes of pregnancies with hypoglycemia fol-
lowing a second trimester oral GCT to pregnancies with a
normal GCT
Methods
All pregnant women attending the Obstetric Clinics of the
Naval Medical Center Portsmouth, Portsmouth, VA, and
the Obstetric Clinics at the University of Mississippi Med-
ical Center, Jackson, MS, who had not been diagnosed
with pre-gestational diabetes or who had not been
screened and identified as having diabetes prior to 24
weeks gestation were eligible for this study. Prospectively,
these women routinely had a 1-hour 50-gram oral GCT as
a screen for gestational diabetes performed at 24–28
weeks of gestational age. Hypoglycemia on the one hour
oral GCT was defined for this investigation as it has been
defined by others as a glucose level ≤ 88 mg/dl (4.8 m/
mol) [1,11]. All women with a one hour glucose of ≤ 88
mg/dL (4.8 m/mol) (hypoglycemic group) were identi-
fied and normoglycemic controls the next patient with a
one hour glucose following the glucose challenge test of
89 – 139 mg/dL (4.9–7.7 m/mol). Women with 1-hour
glucose of ≥ 140 mg/dl (7.7 m/mol) following the 50-
gram oral GCT would undergo a 3-hour glucose tolerance
test with a 100-gram glucose load. A data sheet was com-
pleted and antenatal, intrapartum, and neonatal out-
comes of the hypoglycemic group were compared with
the normal group. Each patient was assigned a study
number, and there were no patient identifiers on the data
collection sheet.
This study was approved by the Chief, Navy Bureau of
Medicine and Surgery, Washington, DC, through the local
Clinical Investigation Program (Naval Medical Center –
Portsmouth) (PO5-051). Approval was also obtained
through the Investigation Review Board at the University
of Mississippi Medical Center, Jackson, MS. The sharing of
information between the 2 institutions was approved
through the Navy Clinical and Cooperative Research and
Development Agreement between the Naval Medical
Center – Portsmouth and the University of Mississippi
Medical Center (NMCP – 05–054).
We recruited 436 women with hypoglycemia and 434
women with normal blood glucose on the GCT to detect
odds ratios ≥ 2.50 with 80% power for association
between hypoglycemia and adverse pregnancy outcomes
such as IUGR and preeclampsia when using multivariable
logistic regression analysis.
Data were summarized using means and standard devia-
tions or medians and interquartile ranges (IQR) for con-
tinuous data, depending on data normality. Frequency
distributions were used to summarize categorical data.
Univariate comparisons between women with hypoglyc-
emia and normal glycemic controls were based on Mann-
Whitney tests for continuous outcomes and Chi-square
tests for categorical outcomes. Supplementary analyses
utilized logistic regression modeling to investigate factors
simultaneously associated with each pregnancy outcome
considered such as preeclampsia, preterm delivery and
IUGR. Odds ratios (OR) and 95% confidence intervals
(CI) were used to summarize the covariate effects on the
outcomes of interest. Relative risks have been obtained
using the group prevalence of each outcome considered
and OR estimates from the logistic regression analysis
[12]. Statistical analysis was conducted using SPSS statisti-
cal software (SPSS, Inc., Version 11.0, Chicago, Illinois).
P-values < 0.05 were considered statistically significant.
Results
Eight hundred seventy women were recruited (436 and
434 with GCT ≤ 88 mg/dL (4.8 m/mol) and GCT range
89–139 mg/dL (4.9–7.7 m/mol) respectively) into the
study between September 2004 and May 2006. Groups
were similar in race, gravidity, parity and pregnancy
weight gain (Table 1). Compared to women with normal
GCT, hypoglycemic women were younger (24.7 vs. 25.9
years of age, p < 0.001), had lower pre-pregnancy weight
(150 lb vs. 157 lb, p = 0.003) and lower pre-pregnancy
BMI (27.0 vs. 26.5, p = 0.002). Higher rates of pre-existing
medical conditions (12% vs. 5%, p < 0.001), prenatal
complications (18% vs. 10%, p < 0.001) and antepartum
hospitalizations (12% vs. 6%, p = 0.002) were found in
hypoglycemic women (Table 1). Higher proportion ofReproductive Health 2009, 6:10 http://www.reproductive-health-journal.com/content/6/1/10
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hypoglycemic women required induction of labor (30%
vs. 20%, p < 0.0010) for a variety of reasons including
rupture of the membranes without labor, non-reassuring
antenatal testing, oligohydramnios, preeclampsia, intrau-
terine growth restriction, and preterm premature rupture
of the membranes, Table 2). However, no differences in
frequency of cervical ripening (p = 0.792), modes of deliv-
ery (p = 0.364) and reasons for cesarean delivery (p =
0.572) were found. Although the median gestational ages
at delivery did not significantly differ between the groups,
preterm deliveries were more frequent in the hypoglyc-
emic group (p = 0.019).
Neonatal outcomes are shown in Table 3. Neonates born
to women with hypoglycemia were of lower birth weight
(median 3240 gm vs. median 3313 gm, p = 0.008). Simi-
larly, the distribution of birth weight was different (p =
0.002), with a higher proportion of neonates with a birth
weight less than 2500 gm in women with hypoglycemia.
These differences, however, were not reflected in the inci-
dence of IUGR which was similar in both groups (12%
and 9% for hypoglycemic and control women, respec-
tively, p = 0.277). Incidence of pH<7.1 and Apgar scores
<7 at 5 minutes were similar between the groups (p =
0.130 and p = 0.374). No differences between admission
to the NICU were found (p = 0.149).
Three perinatal deaths occurred in the study, 2 in the
hypoglycemic group and 1 in control women. The perina-
tal death in the control group was a neonate delivered at
36 weeks after prolonged rupture of the membranes that
died in the NICU of sepsis. The first of the 2 deaths in the







Maternal age(1) 24.7 ± 5.4 25.9 ± 5.5 0.001
Race
Caucasian 179 (41%) 204 (47%)
African American 214 (49%) 187 (43%)
Other 38 (9%) 38 (9%) 0.179
Primigravidas 149 (34%) 149 (34%) 0.941
Nulliparous 190 (44%) 200 (46%) 0.421
Height (in)(2) 65 (63 – 67) 64 (63 – 67) 0.931
Pre-pregnancy weight (lb)(2) 150 (129 – 180) 157 (135 – 190) 0.003
Pre-pregnancy BMI (2) 24.7 (21.8 – 29.5) 26.5 (22.9 – 32.3) 0.002
BMI
<19 22 (7%) 15 (5%) 0.056
19–30 232 (69%) 209 (63%)
≥30 82 (24% 107 (32%)
Pregnancy weight gain (lb)(2) 33.0 (22.0–43.0) 32.0 (20.0 – 43.5) 0.393
History of spontaneous preterm birth 30 (7%) 23 (5%) 0.330
Any pre-existing medical conditions 54 (12%) 23 (5%) <0.001
Chronic hypertension(3) 42 (78%) 19 (83%) 0.442
Other conditions(3,4) 12 (22%) 4 (17%) 0.764
Any prenatal complications 79 (18%) 44 (10%) <0.001
Preeclampsia/eclampsia 35 (8%) 10 (2%) <0.001
Preterm Labor 19 (4%) 15 (4%) 0.600
Oligohydramnios 11 (3%) 1 (0.2%) 0.006
Unexplained elevation of MSFAP 4 (1%) 7 (2%) 0.384
Other prenatal complications(5) 19 (4%) 10 (2%) 0.130
Antepartum hospitalization 53 (12%) 26 (6%) 0.002
Duration of stay (days)(2,3) 3 (3 – 7) 4 (3 – 4) 0.284
(1) mean ± standard deviation shown; (2) medians and interquartile ranges (1st – 3rd quartile) are shown; (3) percentages for subsets of patients 
with condition present are shown; (4) other conditions include gestational diabetes (n = 3), sickle cell disease (n = 3), multiple sclerosis (n = 3), 
PPROM (n = 1), lupus APA syndrome (n = 1), protein C deficiency (n = 1), renal disease (n = 1), seizure disorder (n = 1), ulcerative colitis (n = 1) 
and FV Leiden (n = 1); (5) GHTN (n = 7), PPROM (n = 4), gestational diabetes (n = 4), placenta praevia (n = 3), pyelonephritis (n = 3), 2 vessel cord 
(n = 3), DVT (n = 1), PE (n = 1), cholestasis (n = 1), cerclage (n = 1) and gastroschisis (n = 1).Reproductive Health 2009, 6:10 http://www.reproductive-health-journal.com/content/6/1/10
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hypoglycemia group occurred following a 24 week deliv-
ery with the infant subsequently dying from complica-
tions of prematurity. The second death was a stillborn at
36 weeks secondary to a cord accident.
Multivariable analysis of predictors of hypoglycemia in
pregnancy indicated age, pre-existing medical conditions
and pre-pregnancy BMI categories (<19, 19–30, ≥30) as
simultaneously significant risk factors. Age under 25 years
(OR = 1.61, 95% CI 1.18–2.22, p = 0.003) and presence
of pre-existing medical conditions (OR = 4.02, 95% CI
2.22–7.27, p < 0.001) increased the likelihood of
hypoglycemia. Compared to women with pre-pregnancy
BMI between 19 and 30, women with BMI ≥ 30 had a
lower risk of hypoglycemia (OR = 0.60, 95% CI 0.42–
0.87, p = 0.008), while women with BMI < 19 had similar
likelihood of hypoglycemia in pregnancy (OR = 1.20,
95% CI 0.60–2.37, p = 0.608).
Evaluation of effects of hypoglycemia on pregnancy out-
comes in multivariable logistic regression analyses indi-
cated that, compared to women with 1 hour glucose
between 89 and 139 mg/dL, women with hypoglycemia
were more likely to develop preeclampsia/eclampsia (OR
= 3.13, 95% CI 1.51–6.51, p = 0.002). Another simultane-
ous predictor of preeclampsia/eclampsia was presence of
pre-existing hypertension (OR = 7.29, 95% CI 3.61–
14.75, p < 0.001), while presence of other pre-existing
medical conditions did not alter the risk (OR = 1.36, 95%
CI 0.17–10.81, p = 0.769). Sensitivity of hypoglycemia in
pregnancy for prediction of preeclampsia had 77.8% sen-
sitivity, 51.4% specificity, 8% positive predictive power
and 97.7% negative predictive power.
Hypoglycemia in pregnancy was not related to an indi-
cated induction of labor (OR = 1.75, 95% CI 0.83–1.66, p
= 0.361), once other risk factors were simultaneously con-







Cervical ripening 36 (8%) 38 (9%) 0.792
Induction of labor 129 (30%) 87 (20%) <0.001
Delivery mode
Spontaneous vaginal 314 (72%) 295 (68%)
Assisted vaginal 15 (3%) 14 (3%)
Cesarean section 107 (25%) 125 (29%) 0.364
Reason for cesarean section(1)
Fetal distress 26 (24%) 23 (18%)
Failure to progress 24 (22%) 36 (29%)
Repeat cesarean section 35 (32%) 46 (37%)
Breech/transverse lie 11 (10%) 9 (7%)
Other 11 (10%) 11 (9%) 0.572
Reason for assisted vaginal delivery(1)
Fetal distress 12 (80%) 10 (71%)
Other 3 (20%) 4 (29%) 0.682
Fetal distress in labor 38 (9%) 33 (8%) 0.621
Cesarean delivery for fetal distress 26 (6%) 23 (5%) 0.769
Gestational age at delivery (med, min-max) 39 (23–41.5) 39 (28.6–41.6) 0.689
Gestational age distribution
<37 67 (15%) 43 (10%)
37–40 242 (56%) 273 (63%)
>40 127 (29%) 118 (27%) 0.024
Gestational age at delivery <37 67 (15%) 43 (10%) 0.015
(1) Percentages for subsets of patients with condition present are shown.Reproductive Health 2009, 6:10 http://www.reproductive-health-journal.com/content/6/1/10
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sidered including age under 25 (OR = 2.18, 95% CI 1.53–
3.11, p < 0.001), presence of preeclampsia/eclampsia (OR
= 11.63, 95% CI 5.23–25.85, p < 0.001), presence of pre-
existing medical conditions (OR = 2.77, 95% CI 1.60–
4.81, p < 0.001), and gestational age at delivery (p <
0.001).
Hypoglycemia in pregnancy appeared not to be related to
the likelihood of preterm delivery (OR = 1.61, 95% CI
0.92–2.82, p = 0.093) when the adjustments for preec-
lampsia/eclampsia (OR = 9.05, 95% CI 4.28–19.16, p <
0.001) and preterm labor (OR = 39.34, 95% CI 16.31–
94.87, p < 0.001) were made. No effects of hypoglycemia
in pregnancy were associated with fetal distress in labor,
cesarean delivery, IUGR, low pH, low Apgar scores at 5
minutes, or admissions to a NICU after adjusting for other
risk factors (Table 4). No multivariable assessment of oli-
gohydramnios was performed due to the small number of
cases (n = 12).
Discussion
Nearly universal screening of pregnant women is under-
taken with a one hour GCT between 24 and 28 weeks of
gestation except in women who are diabetic prior to the
pregnancy or who have risk factors for diabetes and are
screened at an earlier gestational age. Elevated blood glu-
coses on the one hour screen lead to further evaluation
with a three hour glucose tolerance test. To date, an asso-
ciation of low blood glucoses to adverse pregnancy out-
come remains uncertain. The literature that is present on







Birth weight (gm) (med, Q1-Q3) 3240 (2928–3550) 3313 (2980–3690) 0.008
Birth weight distribution
<2500 43 (10%) 22 (5%)
2500–4000 370 (85%) 370 (85%)
>4000 23 (5%) 42 (10%) 0.002
IUGR 36 (12%) 29 (9%) 0.277
Umbilical artery pH<7.1 14 (3%) 7 (2%) 0.130
5 minutes Apgar score <7 4 (1%) 1 (.2%) 0.374
Admission to NICU 36 (8%) 25 (6%) 0.149
Admission reasons(2)
Prematurity 6 (17%) 4 (16%)
RDS/TTN 26 (72%) 12 (48%)
Other(2) 4 (11%) 9 (36%) 0.054
(1) Medians and interquartile ranges (1st quartile – 3rd quartile) are shown; (2) percentages for subsets of patients with condition present are shown.
Table 4: Adjusted odds ratios (OR) and the equivalent relative risks (RR) with their 95% confidence intervals (CI) that reflect the 
effects of hypoglycemia on select perinatal outcomes
Outcome OR 95% CI RR 95% CI p-value
Preeclampsia 3.13 1.51–6.51 2.98 1.49–5.78 0.002
Induction of labor 1.75 0.83–1.66 1.52 0.86–1.47 0.361
Preterm delivery 1.61 0.92–2.82 1.52 0.93–2.39 0.093
IUGR 1.24 0.73–2.10 1.21 0.75–1.91 0.425
Macrosomia 0.49 0.28–0.85 0.51 0.30–0.86 0.011
Umbilical artery pH<7.1 2.00 0.76–5.26 1.97 0.77–4.93 0.159
5 min Apgar score <7 1.97 0.20–19.91 1.97 0.20–19.19 0.564
NICU admission 1.27 0.62–2.05 1.12 0.63–1.94 0.965
Preeclampsia: presence of pre-existing hypertension, presence of other medical history, maternal age.
Induction of labor: any pre-existing medical history, gestational age, preeclampsia, maternal age.
Preterm delivery: preeclampsia, antenatal hospitalizations, threatened preterm labor, labor induction.
IUGR: gestational age at delivery, pre-existing medical conditions present.
Macrosomia: maternal age, preeclampsia and gestational age at delivery.
Umbilical artery pH<7.1: gestational age at delivery and mode of delivery.
5 min Apgar < 7: gestational age at delivery and induction of labor.
NICU admission for any reason: gestational age at delivery, fetal distress in labor, cesarean delivery, IUGR, macrosomia.Reproductive Health 2009, 6:10 http://www.reproductive-health-journal.com/content/6/1/10
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hypoglycemia and pregnancy outcomes is old and a vari-
ety of glucose challenge tests have been used to define
hypoglycemia in pregnancy. This study evaluated the pre-
dictability of a laboratory result that is widely available on
pregnant women and its possible association with an
unfavorable pregnancy outcome.
Conditions were identified by multivariate analysis in
which the participants would be more likely to have
hypoglycemia on the GCT. They include a maternal age <
25 years and the presence of preexisting medical condi-
tions (chronic hypertension, chronic renal disease, throm-
bophilia, lupus, and seizure disorders). However, no
difference in the risk of hypoglycemia was observed
between women with a pre-pregnancy BMI of 19–30 vs.
those with a BMI < 19, but as expected, women with a BMI
> 30 had a significantly reduced incidence of hypoglyc-
emia. This finding is consistent with the observation that
women with a pre-pregnancy BMI > 30 are more likely to
develop gestational diabetes and would therefore more
likely have a blood glucose > 140 mg/dL (7.7 m/mol) on
GCT [13].
The pregnancy effects of maternal hypoglycemia were
then evaluated. Multivariate analysis revealed that women
with hypoglycemia were more likely to develop preec-
lampsia/eclampsia. This result has not been reported
before to our knowledge although in our pilot study the
incidence of preeclampsia approached significance in
those women with hypoglycemia following the GCT. We
do acknowledge that the strength of this association is cur-
rently uncertain, as we have no precise information on the
time that the glucose challenge test was undertaken and
when the preeclampsia was diagnosed in each of the
patients. The relationship was assumed based on an
implicit close relationship in gestational age of the diag-
nosis of the hypoglycemia and the development of the
preeclampsia. We can speculate that since preeclampsia is
present early in pregnancy and alters placental implanta-
tion with a failure of vascular remodeling, the maternal/
placental function is affected. Rather than an increasing
resistance to insulin with the production of HPL by the
placenta and other diabetogenic hormones and factors, as
is observed in a normal pregnancy, these would be
reduced resulting in less insulin resistance and a greater
tendency for hypoglycemia following a glucose challenge
test. The vasospasm of preeclampsia could also play some
unknown role in altering the maternal response to a glu-
cose load. Further investigations are needed to clarify if a
relationship does exist between glucose loading and
women who subsequently develop preeclampsia, and if
so, the pathophysiology of that maternal response.
Indicated inductions of labor for a variety of reasons
including rupture of membranes without labor, non reas-
suring antenatal testing, oligohydramnios, preeclampsia,
intrauterine growth restriction and preterm premature
rupture of the membranes were more commonly identi-
fied in the hypoglycemic group compared with women
with a normal glucose following the GCT. As expected,
this would suggest that women develop a variety of prob-
lems in the latter part of pregnancy that would result in an
indicated induction. Hypoglycemia was also associated
with a significant reduction in fetal macrosomia. This is
not an unexpected finding as the hyperglycemia of gesta-
tional diabetes is linked with a greater risk of fetal macro-
somia.
Also notable was the lack of association between hypogly-
cemia and preterm labor and/or delivery. The women
with hypoglycemia were not at increased risk compared to
women with a normal GCT for fetal distress in labor,
cesarean delivery, low Apgar scores, low cord pH or
admission to a neonatal intensive care unit. The lack of
correlation between hypoglycemia and intrauterine
growth retardation is different from the finding of most
other investigators [1-7,9], except for 2 of the more recent
studies which also evaluated hypoglycemia after the 50
gram oral glucose challenge test [8,11]. The older studies
used a variety of techniques to identify the hypoglycemic
pregnancies including higher both oral and IV glucose
loading than that achieved with the oral 50-gram load as
in our screening protocol. One possible explanation is
that pregnancies identified as hypoglycemic by higher pre-
test loads identify pregnancies in which the fetuses
become growth restricted, but that the lower load with the
50-gram dose does not categorize the same women as
hypoglycemic. Different patient demographics and differ-
ent definitions of intrauterine growth restriction may also
have contributed to the lack of significance with hypogly-
cemia in this study. Intrauterine growth restriction, low
Apgar scores, umbilical artery pH and NICU admissions
were all seen more frequently in the hypoglycemic group
compared to the control group but the findings were not
statistically significantly different. Even though this was a
large prospective study with 870 women the possibility of
a sample size error must be taken into consideration and
that with larger number of participants a significant differ-
ence may be observed.
One of the weaknesses of this study may be that the glu-
cose load to identify the pregnancies which are linked to
an adverse pregnancy outcome may be too low. However,
this must be balanced with the availability and ease of
administration of the test. Use of the 50-gram load is very
appealing to most pregnant women undergoing this test
in the second trimester of pregnancy. The strength of this
study is the large number of prospectively matched
women which was evaluated and the multiple analyses
undertaken to accurately determine which women arePublish with BioMed Central    and   every 
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more likely to become hypoglycemic and the outcomes of
those pregnancies.
Future investigations are needed to clearly describe the
associations between women who are hypoglycemic fol-
lowing a glucose challenge, women with one abnormal
value on a glucose tolerance test, and women with 2
abnormal values (gestational diabetics) with adverse preg-
nancy outcomes. The use of additional diagnostic tests
such as the homeostasis model assessment (HOMA) with
both insulin resistance (HOMO-IR) and beta cell function
(HOMO-BETA) may well prove to be beneficial in further
understanding of the links between maternal glucose and
their effects on pregnancies. The observed association
between hypoglycemia and oligohydramnios and the
known link between hyperglycemia and hydramnios in
addition to the witnessed relationship between oligohy-
dramnios and intrauterine growth restriction and
hydramnios with macrosomia provide a very fruitful area
for further investigations to assist in the understanding of
the role of maternal glucose and these connections.
Conclusion
Women with hypoglycemia on GCT are younger and
more likely to have a pre-existing medical condition prior
to pregnancy. They may be more likely to develop preec-
lampsia during pregnancy but not intrauterine growth
restriction.
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